Stephen D Anesi, Peter Y Chang, Arash Maleki, Andrew Stephenson, Alyssa Montieth, Artur Filipowicz, Sarah Syeda, Soheila Asgari, Marisa Walsh, Jamie Lynne Metzinger, C Stephen Foster
Purpose: To show whether subcutaneous repository corticotropin injection (RCI, Acthar® Gel, a repository corticotropin injection, can be an effective potential therapeutic agent for noninfectious retinal vasculitis. Methods: Patients with active retinal vasculitis were followed with serial ultra-wide-field fluorescein angiograms and treated with 80 units of subcutaneous repository corticotropin injection twice weekly. Results: Primary outcome of <mml:math xmlns:mml="https://www...
April 2021: Journal of Ophthalmic & Vision Research